Crawford Fund Management, LLC Adaptive Biotechnologies Corp Transaction History
Crawford Fund Management, LLC
- $466 Billion
- Q3 2024
A detailed history of Crawford Fund Management, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Crawford Fund Management, LLC holds 13,000 shares of ADPT stock, worth $81,770. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,000Holding current value
$81,770% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ADPT
# of Institutions
202Shares Held
146MCall Options Held
68.8KPut Options Held
42.5K-
Viking Global Investors LP30MShares$189 Million0.59% of portfolio
-
Rubric Capital Management LP New York, NY14.4MShares$90.6 Million2.05% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$73.4 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.6MShares$73 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$66.9 Million0.0% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $899M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...